Chewy reported Q2 results largely in line with expectations, with net sales up 7.3% to $3.33 billion and adjusted earnings matching forecasts at $0.36 per share. However, shares fell 10.8% due to concerns about slowing organic growth, cautious consumer spending, and rising competition. The company raised its fiscal 2026 net sales guidance to $13.46-$13.57 billion but below its original forecast, signaling ongoing demand caution. Analysts remain divided, with Morgan Stanley seeing 73.5% upside potential at a $36 target, while Evercore ISI downgraded the stock to In Line with a $25 target due to market challenges.
Chewy reported better-than-expected Q2 results driven by organic sales growth and an expanding customer base. The company is diversifying revenue by expanding into veterinary care clinics, reducing reliance on pet food and toy sales. Key performance ...
Chewy's stock fell 11% after reporting a free cash flow decline despite beating revenue estimates and raising its full-year outlook. The cash flow shortfall is linked to increased capital expenditures from acquisitions and integration costs, causing ...
Chewy reported quarterly earnings of $0.36 per share, doubling analyst estimates of $0.18, with net income rising to $80.5 million from $62 million a year ago. Quarterly revenue reached $3.33 billion, slightly above expectations, marking a 7.3% incre...
Chewy Inc reported Q2 revenue of $3.33 billion and adjusted earnings per share of $0.36, both surpassing analyst expectations. Adjusted EBITDA rose 23.7% to $226.7 million, with margins improving, yet free cash flow dropped 15.5% to $89.5 million, mi...
US stock futures dipped slightly as oil prices approached $100 per barrel due to rising tensions between the US and Iran. This increase in crude prices has intensified speculation that the Federal Reserve will raise interest rates by 25 basis points ...
